Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism

Codes Discussed: D50-D89 (Diseases of the blood and blood-forming organs and certain immune disorders), D62 (Acute posthemorrhagic anemia), D50.0 (Iron deficiency anemia secondary to blood loss/chronic blood loss anemia), Z67 (Blood type category), Z67.11 (Type A blood, Rh negative), Z79.01 (Long term current use of anticoagulants), Z51.81 (Encounter for therapeutic drug level monitoring), D55-D59 (Hemolytic anemias code range), D60-D64 (Aplastic and other anemias code range), D61.81 (Pancytopenia category), D61.818 (Other pancytopenia), D63 (Anemia in chronic diseases classified elsewhere category), D63.0 (Anemia in neoplastic disease), D61.1 (Drug-induced aplastic anemia/aplastic anemia due to chemotherapy), D65 (Disseminated intravascular coagulation/defibrination syndrome), D66 (Hereditary factor VIII deficiency/Hemophilia A/classic hemophilia), D67 (Hereditary factor IX deficiency/Hemophilia B/Christmas disease), D68.0 (Von Willebrand disease category), D68.32 (Hemorrhagic disorder due to extrinsic circulating anticoagulants), D68.318 (Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors), T45.515A (Adverse effect of anticoagulants, initial encounter), D75.83 (Thrombocytosis category), D70 (Neutropenia category), D70.2 (Drug-induced neutropenia), D73 (Diseases of spleen category), D72.1 (Eosinophilia category/hypereosinophilic syndrome category), D84.8 (Other immunodeficiencies category), D84.81 (Immunodeficiency due to conditions classified elsewhere), D84.821 (Immunodeficiency due to drugs), D84.822 (Immunodeficiency due to external causes), B20 (Human immunodeficiency virus disease/AIDS), D81.4 (Nezelof’s syndrome), D89.83 (Cytokine release syndrome category), D89.81 (Graft-versus-host disease category), D89.810 (Acute graft-versus-host disease), R04.0 (Epistaxis/nosebleed), C50.912 (Malignant neoplasm of unspecified site of left female breast), D64.81 (Anemia due to antineoplastic chemotherapy), D64.9 (Anemia, unspecified), D70.9 (Neutropenia, unspecified), D69.6 (Thrombocytopenia, unspecified), D63.8 (Anemia in other chronic diseases classified elsewhere), K92.2 (Gastrointestinal hemorrhage, unspecified), D57.00 (Hb-SS disease with crisis, unspecified), C61 (Malignant neoplasm of prostate), T45.1X5A (Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter), Z90.49 (Acquired absence of other specified parts of digestive tract), J18.9 (Pneumonia, unspecified organism), C91.10 (Chronic lymphocytic leukemia of B-cell type not having achieved remission), T86.09 (Other complications of bone marrow transplant), R10.9 (Unspecified abdominal pain), R11.2 (Nausea with vomiting, unspecified), R21 (Rash and other nonspecific skin eruption), C91.01 (Acute lymphoblastic leukemia, in remission)

Topics Covered: ICD-10-CM blood disorder coding, ICD-10-CM immune disorder coding, ICD-10-CM Chapter 3 coding, diseases of the blood and blood-forming organs, immune mechanism disorders, blood anatomy and physiology, blood functions, blood plasma, serum, plasma proteins, albumins, globulins, immune globulins, antibodies, clotting factors, fibrinogen, complement proteins, enzymes, enzyme inhibitors, electrolyte transporters, lipoproteins, erythrocytes, red blood cells, RBCs, hemoglobin, oxygen transport, iron and hemoglobin synthesis, reticulocytes, reticulocyte count, leukocytes, white blood cells, WBCs, granulocytes, agranulocytes, phagocytes, immunocytes, neutrophils, eosinophils, basophils, polymorphonuclear leukocytes, PMNs, lymphocytes, B-cells, T-cells, monocytes, macrophages, thrombocytes, platelets, megakaryocytes, blood clotting, coagulation coding, hemorrhage control, erythropoiesis, erythroblasts, normoblasts, megaloblasts, leukoblasts, lymphatic system, lymph nodes, lymphoid organs, thymus, bone marrow, spleen, tonsils, splenectomy infection risk, hematopoiesis, hemocytoblasts, red bone marrow, yellow bone marrow, myeloid tissue, hemostasis, coagulation cascade, primary hemostasis, secondary hemostasis, vasospasm, vasoconstriction, platelet aggregation, platelet plug, fibrin clot formation, clot dissolution, blood tests for coding queries, serology, antigens, antibodies, IgM, IgG, acute infection serology, past infection immunity, Excludes1 notes, Excludes2 notes, blood type coding, Rh factor coding, anticoagulant therapy coding, long-term anticoagulant use coding, therapeutic drug monitoring coding, anticoagulation lab monitoring, anemia coding, nutritional anemia coding, deficiency anemia coding, iron deficiency anemia coding, vitamin B12 deficiency anemia, folate deficiency anemia, hemolytic anemia coding, thalassemia coding, sickle cell disorder coding, sickle cell crisis coding, aplastic anemia coding, Blackfan-Diamond syndrome, pure red cell aplasia, pancytopenia coding, thrombocytopenia coding, leukopenia coding, blood loss anemia coding, acute blood loss anemia coding, chronic blood loss anemia coding, acute on chronic anemia coding, anemia in chronic disease coding, anemia in neoplastic disease coding, anemia due to malignancy coding, anemia due to chemotherapy coding, anemia sequencing guidelines, neoplasm anemia sequencing, antineoplastic therapy adverse effect coding, disseminated intravascular coagulation coding, DIC coding, defibrination syndrome coding, coagulation defect coding, hemophilia coding, Hemophilia A coding, factor VIII deficiency coding, classic hemophilia, Hemophilia B coding, Christmas disease, factor IX deficiency coding, Von Willebrand disease coding, VWD coding, inherited bleeding disorder coding, hemorrhagic disorder due to circulating anticoagulants, intrinsic circulating anticoagulant coding, extrinsic circulating anticoagulant coding, Coumadin bleeding coding, supratherapeutic INR coding, epistaxis due to anticoagulation, adverse effect T code sequencing, purpura coding, hemorrhagic condition coding, primary thrombocytopenia coding, secondary thrombocytopenia coding, idiopathic thrombocytopenic purpura, ITP coding, heparin-induced thrombocytopenia, thrombocythemia coding, thrombocytosis coding, essential thrombocytosis, reactive thrombocytosis, neutropenia coding, agranulocytosis coding, neutropenic fever coding, drug-induced neutropenia coding, spleen disorder coding, hypersplenism coding, splenic sequestration coding, splenic sequestration crisis, sarcoidosis coding, autoimmune disease coding, granuloma coding, hilar adenopathy, hypereosinophilic syndrome coding, eosinophilia coding, pulmonary eosinophilia coding, immunodeficiency coding, immunodeficiency due to leukemia, immunodeficiency due to conditions classified elsewhere, immunodeficiency due to drugs, immunodeficiency due to external causes, AIDS Excludes1 coding, Nezelof syndrome coding, cytokine release syndrome coding, CRS coding, CAR T-cell therapy complication coding, cytokine release syndrome severity grading, graft-versus-host disease coding, GVHD coding, acute GVHD coding, bone marrow transplant complication coding, transplant rejection distinction, blood transfusion complication coding, manifestation coding with GVHD, Code Purple practice, Code Red assessment, blood and immunity coding scenarios